Actionable PGx Testing Tailored for Multiple Ethnicities
RPRD’s PGx 25 Gene Panel provides highly actionable and extensive insights to help the healthcare providers make informed prescription decisions for the patients. We are proud to offer the most inclusive coverage of the pharmacogenetics (PGx) relevant alleles/variants that are important when analyzing diverse populations. Our test report incorporates the most up-to-date clinical and scientific guidance from the key PGx scientific and government organizations, including Clinical Pharmacogenomics Implementation Consortium (CPIC), Pharmacogene Variation Consortium (PharmVar) and Federal Drug Administration (FDA).
The gene coverage of the panel has been selected and curated by RPRD’s clinicians and scientists following strong peer-reviewed scientific evidence and industry’s highest standard of actionability. The PGx 25 Gene Panel report strictly adheres to the recommendations by the CPIC clinical guidelines and the FDA drug labeling, with clear annotations and references.
Tailored for multiple ethnicities
RPRD’s PGx 25 Gene Panel covers a broad array of genetic alleles/variants of the key PGx genes. It investigates the common, rare, and ethnicity-specific genetic alleles that are important for diverse populations. It generates inclusive and ethnicity-unbiased highly accurate testing results that the providers and patients can trust.
RPRD accepts whole blood or saliva sample. If you choose to send your patient’s saliva sample, RPRD can send the collection kits either directly to your patient’s home, or to your office, free of charge.
RPRD’s PGx testing is fully CLIA-certified clinical grade genetic testing. Only a fully licensed healthcare provider or a genetic counselor who treats the patient can order the test.
Please download and fill out the Test Requisition Form. Please send the completed TRF together with the patient’s sample to us, or fax it directly to RPRD and we will arrange the sample home collection directly with the patient. If an insurance billing payment option is chosen, please contact us to establish the billing process first.
All our tests that are for clinical decision making should be ordered by a licensed healthcare provider or a genetic counselor. Pharmacists play a critical role in integrating PGx into patient care. In the United States, in general, the pharmacists need collaborative practice agreements in place to order the test. However, certain States might have the specific state laws regulating pharmacists’ ability to order and interpret lab test.
Patient’s out-of-pocket cost may vary depending on the patient’s health insurance plan. RPRD will contact the patient’s insurance provider to understand the potential total out-of-pocket cost (estimated only). We promise only to process the test if the patient is comfortable with the cost. RPRD also offers Financial Assistance Program to the eligible patients, to help reduce the out-of-pocket cost.
If you have any questions about your patient’s test result or need any help to understand the report, our board-certified medical geneticist and experienced PGx scientists are available to guide you through the test result and answer any questions.
We do not offer consultation to the patients directly.